Morphic Therapeutic Is A Biopharmaceutical Company Dedicated To Developing Oral Integrin Therapies Aimed At Treating Serious Chronic Diseasesparticularly Those Related To Inflammation And Axonal Degenerationthe Company Focuses On Creating Disease Modifying Therapeutics That Utilize Small Molecule Drugswhich Can Be Taken Orallyproviding A Convenient Alternative To Traditional Injectable Treatments Morphic Therapeutic Has Engaged In Significant Partnerships With Major Pharmaceutical Companiesincluding A Collaboration With Janssen Biotech To Develop Novel Integrin Therapeuticsin July 2024Eli Lilly Announced Plans To Acquire Morphic Therapeuticintending To Enhance Patient Outcomes In Inflammatory Diseases By Incorporating Morphic S Innovative Therapies Into Its Portfoliothis Acquisition Is Expected To Strengthen Lilly S Offerings In The Treatment Of Chronic Conditions
No conferences found for this company.
| Company Name | Morphic Therapeutic Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
